Article

jdsupra.comjdsupra.com on 2020-08-21 21:41

Valeant Pharms Int’l, Inc. v. Mylan Pharms Inc.

BECAUSE THE PRIOR ART TAUGHT OVERLAPPING PH RANGES AND STRUCTURALLY SIMILAR COMPOUNDS AS THOSE CLAIMED IN THE PATENT-IN-SUIT, THE FEDERAL CIRCUIT ...

Related news